Literature DB >> 33758244

Acitretin reverses early functional network degradation in a mouse model of familial Alzheimer's disease.

Ulrich Schmitt1,2, Kristina Endres1, Albrecht Stroh3,4,5, Eduardo Rosales Jubal6,7,8, Miriam Schwalm9,10,11,12, Malena Dos Santos Guilherme1, Florian Schuck1, Sven Reinhardt1, Amanda Tose9,10,13, Zeke Barger9,10,13, Mona K Roesler14, Nicolas Ruffini2, Anna Wierczeiko2, Michael J Schmeisser9,14.   

Abstract

Aberrant activity of local functional networks underlies memory and cognition deficits in Alzheimer's disease (AD). Hyperactivity was observed in microcircuits of mice AD-models showing plaques, and also recently in early stage AD mutants prior to amyloid deposition. However, early functional effects of AD on cortical microcircuits remain unresolved. Using two-photon calcium imaging, we found altered temporal distributions (burstiness) in the spontaneous activity of layer II/III visual cortex neurons, in a mouse model of familial Alzheimer's disease (5xFAD), before plaque formation. Graph theory (GT) measures revealed a distinct network topology of 5xFAD microcircuits, as compared to healthy controls, suggesting degradation of parameters related to network robustness. After treatment with acitretin, we observed a re-balancing of those network measures in 5xFAD mice; particularly in the mean degree distribution, related to network development and resilience, and post-treatment values resembled those of age-matched controls. Further, behavioral deficits, and the increase of excitatory synapse numbers in layer II/III were reversed after treatment. GT is widely applied for whole-brain network analysis in human neuroimaging, we here demonstrate the translational value of GT as a multi-level tool, to probe networks at different levels in order to assess treatments, explore mechanisms, and contribute to early diagnosis.

Entities:  

Year:  2021        PMID: 33758244     DOI: 10.1038/s41598-021-85912-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  67 in total

Review 1.  The Cellular Phase of Alzheimer's Disease.

Authors:  Bart De Strooper; Eric Karran
Journal:  Cell       Date:  2016-02-11       Impact factor: 41.582

Review 2.  The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes.

Authors:  Iryna Benilova; Eric Karran; Bart De Strooper
Journal:  Nat Neurosci       Date:  2012-01-29       Impact factor: 24.884

3.  Altered structural network organization in cognitively normal individuals with amyloid pathology.

Authors:  Olga Voevodskaya; Joana B Pereira; Giovanni Volpe; Olof Lindberg; Erik Stomrud; Danielle van Westen; Eric Westman; Oskar Hansson
Journal:  Neurobiol Aging       Date:  2017-12-07       Impact factor: 4.673

4.  Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease.

Authors:  Marc Aurel Busche; Gerhard Eichhoff; Helmuth Adelsberger; Dorothee Abramowski; Karl-Heinz Wiederhold; Christian Haass; Matthias Staufenbiel; Arthur Konnerth; Olga Garaschuk
Journal:  Science       Date:  2008-09-19       Impact factor: 47.728

5.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

Authors:  R Brookmeyer; S Gray; C Kawas
Journal:  Am J Public Health       Date:  1998-09       Impact factor: 9.308

Review 6.  Neuropathological alterations in Alzheimer disease.

Authors:  Alberto Serrano-Pozo; Matthew P Frosch; Eliezer Masliah; Bradley T Hyman
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

7.  Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks.

Authors:  Kishore V Kuchibhotla; Samuel T Goldman; Carli R Lattarulo; Hai-Yan Wu; Bradley T Hyman; Brian J Bacskai
Journal:  Neuron       Date:  2008-07-31       Impact factor: 17.173

Review 8.  Alzheimer's disease and the amyloid-beta peptide.

Authors:  M Paul Murphy; Harry LeVine
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

9.  Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study.

Authors:  Eric M Reiman; Yakeel T Quiroz; Adam S Fleisher; Kewei Chen; Carlos Velez-Pardo; Marlene Jimenez-Del-Rio; Anne M Fagan; Aarti R Shah; Sergio Alvarez; Andrés Arbelaez; Margarita Giraldo; Natalia Acosta-Baena; Reisa A Sperling; Brad Dickerson; Chantal E Stern; Victoria Tirado; Claudia Munoz; Rebecca A Reiman; Matthew J Huentelman; Gene E Alexander; Jessica B S Langbaum; Kenneth S Kosik; Pierre N Tariot; Francisco Lopera
Journal:  Lancet Neurol       Date:  2012-11-06       Impact factor: 44.182

Review 10.  Donepezil for dementia due to Alzheimer's disease.

Authors:  Jacqueline S Birks; Richard J Harvey
Journal:  Cochrane Database Syst Rev       Date:  2018-06-18
View more
  2 in total

1.  In Vitro Effects of Acitretin on Human Neuronal SH-SY5Y Cells.

Authors:  Aojie Cai; Nana Liu; Zehong Lin; Xiao Li; Jingmin Wang; Ye Wu; Kai Gao; Yuwu Jiang
Journal:  Neurochem Res       Date:  2022-08-20       Impact factor: 4.414

2.  Lipopolysaccharide-induced neuroinflammation disrupts functional connectivity and community structure in primary cortical microtissues.

Authors:  Elaina Atherton; Sophie Brown; Emily Papiez; Maria I Restrepo; David A Borton
Journal:  Sci Rep       Date:  2021-11-16       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.